The Use of the Mini-Mental State Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs, Ands, Buts, or Sensitivity
- 1 October 2003
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (19) , 3557-3558
- https://doi.org/10.1200/jco.2003.07.080
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State ExaminationJournal of Clinical Oncology, 2003
- Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progressionNeuro-Oncology, 2003
- Pretreatment cognitive performance predicts survival in patients with leptomeningeal diseaseCancer, 2002
- Lead-In Phase to Randomized Trial of Motexafin Gadolinium and Whole-Brain Radiation for Patients With Brain Metastases: Centralized Assessment of Magnetic Resonance Imaging, Neurocognitive, and Neurologic End PointsJournal of Clinical Oncology, 2002
- Adverse long-term effects of brain radiotherapy in adult low-grade glioma patientsNeurology, 2001
- Weighing the benefits and risks of radiation therapy for low-grade gliomaNeurology, 2001
- Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant GliomaJournal of Clinical Oncology, 2000
- Neurocognitive effects of therapeutic irradiation for base of skull tumorsPublished by Elsevier ,2000